NASDAQMaterialsSpecialty ChemicalsSnapshot 2026-07-23
Reading CLMT? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a turnaround opportunity with a medium level of confidence. The current thesis is cautious due to recent earnings misses and a volatile management track record.
The market appears to be pricing in a fragile situation, with an expensive valuation that does not fully reflect the company's weak performance and turbulent environment. There is an expectations gap indicating that the market may not fully account for the risks involved.
Fundamentally, CLMT's performance is neutral, with a recent rise in company quality. However, the company has a history of erratic earnings surprises and is currently on a streak of consecutive earnings misses, which poses a risk.
The future of CLMT hinges on several factors, including the potential for guidance cuts in the next earnings call and the impact of inflation on the Materials sector. Additionally, the performance of sector bellwethers could influence CLMT's trajectory.
Over the next 1 to 3 years, CLMT's outlook remains uncertain due to its loss-making status and elevated risks. Monitoring sector trends and management execution will be crucial. Not investment advice.
The most important moves since the prior daily snapshot.
No, our read on the company is unchanged. There are no new strengths or weaknesses identified that would alter the current assessment. The overall context remains consistent, with management still seen as unsteady and the sector backdrop acting as a drag.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Earnings results will show if Calumet can make more money after a recent miss.
Confirms:Q2 earnings show a loss greater than the previous quarter's loss.
Disproves:Q2 earnings show a smaller loss or a profit.
Why it matters: This report can indicate consumer spending trends. Strong retail sales can signal better demand for Calumet's products.
Confirms one read:Retail sales are up a lot compared to last month.
Confirms the other:Retail sales decline or show weak growth compared to the previous month.
Why it matters: The materials sector is declining. A shift to positive growth could signal recovery for Calumet.
Confirms:Sector data shows three-year revenue growth turning positive.
Disproves:Sector data continues to show revenue decline.
Why it matters: New credit agreements show how Calumet manages its debts. This impacts cash flow and stability.
Confirms one read:Management shares new credit agreements. These will improve cash flow.
Confirms the other:No new credit agreements or bad terms were announced.
Why it matters: Issuing these notes helps manage money needs and cash flow.
Confirms:Company announces it has issued $150M in Senior Notes.
Disproves:Company fails to issue the Senior Notes or delays the process.
Why it matters: Cutting the 2028 notes is important for the company's money health.
Confirms:Company says it has reduced the 2028 notes with extra cash.
Disproves:Company says it has not made progress on the 2028 notes.
Why it matters: Earnings results will show if the company can recover from the recent earnings miss.
Confirms one read:Q2 earnings report shows revenue growth turning positive year over year.
Confirms the other:Q2 earnings report shows revenue decline continues year over year.
Why it matters: The EPA's announcement may help Calumet's biofuel margins a lot.
Confirms:Biofuel margins increase by over 15% in Q2 2026 compared to Q1 2026.
Disproves:Biofuel margins drop or stay the same. This shows no gain from EPA changes.
Why it matters: Successful issuance would help Calumet's cash flow and financial options.
Confirms:Calumet successfully issues the $150M Senior Notes by the end of Q3 2026.
Disproves:No progress on the notes issuance shows ongoing capital problems.
